Journal ArticleDOI
Trends in mortality from cervical cancer in the nordic countries: association with organised screening programmes
TLDR
Investigation of time trends in mortality from cervical cancer in Denmark, Finland, Iceland, Norway, and Sweden since the early 1950s supports the conclusion that organised screening programmes have had a major impact on the reduction in mortality in the Nordic countries.About:
This article is published in The Lancet.The article was published on 1987-05-30. It has received 673 citations till now. The article focuses on the topics: Population.read more
Citations
More filters
Journal ArticleDOI
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors.
TL;DR: This report estimates mortality from 12 types of cancer attributable to nine risk factors in seven World Bank regions for 2001 and suggests reduction of exposure to key behavioural and environmental risk factors would prevent a substantial proportion of deaths from cancer.
Journal ArticleDOI
Overview of the European and North American studies on HPV testing in primary cervical cancer screening.
Jack Cuzick,Christine Clavel,Karl Ulrich Petry,Chris J.L.M. Meijer,Heike Hoyer,Sam Ratnam,Anne Szarewski,Philippe Birembaut,Shalini L Kulasingam,Peter Sasieni,Thomas Iftner +10 more
TL;DR: The results support the use of HPV testing as the sole primary screening test, with cytology reserved for women who test HPV positive, with large demonstration projects needed to fully evaluate this strategy.
Journal ArticleDOI
Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
Ruediger Klaes,Tibor Friedrich,Dimitry Spitkovsky,Ruediger Ridder,Wolfgang Rudy,Ulrich Petry,Gisela Dallenbach-Hellweg,Dietmar Schmidt,Magnus von Knebel Doeberitz +8 more
TL;DR: Data demonstrate that p16INK4a is a specific biomarker to identify dysplastic cervical epithelia in sections of cervical biopsy samples or cervical smears and that Dysplastic cells could also be identified in cervicalsmears using a specific p16ink4a monoclonal antibody.
Journal ArticleDOI
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
TL;DR: A framework to guide individualized cancer screening decisions in older patients may be more useful to the practicing clinician than age guidelines because it anchors decisions through quantitative estimates of life expectancy, risk of cancer death, and screening outcomes based on published data.
Journal ArticleDOI
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Mohammad H. Forouzanfar,Kyle J Foreman,Allyne Delossantos,Rafael Lozano,Alan D. Lopez,Christopher J L Murray,Mohsen Naghavi +6 more
TL;DR: More policy attention is needed to strengthen established health-system responses to reduce breast and cervical cancer, especially in developing countries.
References
More filters
Journal ArticleDOI
Evaluation of screening programmes for gynaecological cancer
TL;DR: This report summarizes the presentations, conclusions and recommendations from the workshop on screening for gynaecological cancer, especially for cancer of the cervix uteri.
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
TL;DR: Time trends and differentials in cancer incidence in the five Nordic countries, Denmark, Finland, Iceland, Norway and Sweden, were investigated, using material collected by the cancer registries in each country by age, birth cohort and time period.
Journal ArticleDOI
Evaluation of Screening for Cervical Cancer in Sweden: Trends in Incidence and Mortality 1958–1980
TL;DR: The age-standardized incidence of invasive carcinoma fell in Sweden in this period by about 40%.
Journal ArticleDOI
Screening for cancer of the uterine cervix in Iceland 1965--1978.
TL;DR: The mortality rates among the unscreened population are more than ten‐fold greater than among the screened population, and the greater part of the fall in mortality is attributed to the mass screening programme.